Sagimet Biosciences (SGMT) Prepaid Assets (2022 - 2026)
Sagimet Biosciences (SGMT) posted quarterly Prepaid Assets of $3.2 million for Q1 2026, up 111.38% year-over-year from $1.5 million in Q1 2025, and up 1496.48% quarter-over-quarter from $199000.0 in Q4 2025.
Sagimet Biosciences (SGMT) Prepaid Assets (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Prepaid Assets history runs 5 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 111.38% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (up 111.38% YoY), while the FY2025 annual figure was $199000.0, down 86.94% from the prior year.
- Prepaid Assets for Q1 2026 stood at $3.2 million, up from $199000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $3.2 million in Q1 2026, with the low at $34000.0 in Q4 2022.
- The 5-year median for Prepaid Assets is $378000.0 (2024), against an average of $873923.1.
- Peak annual rise in Prepaid Assets reached 2659.41% in 2025, while the deepest fall reached 86.94% in 2025.
- Sagimet Biosciences' Prepaid Assets stood at $34000.0 in 2022, then surged by 1620.59% to $585000.0 in 2023, then jumped by 160.51% to $1.5 million in 2024, then tumbled by 86.94% to $199000.0 in 2025, then soared by 1496.48% to $3.2 million in 2026.
- Business Quant data shows SGMT's Prepaid Assets at $3.2 million in Q1 2026, $199000.0 in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Sagimet Biosciences | 649.79 Mn | 649.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.86 Mn |
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | 199,000.00 |
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 103,000.00 |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 101,000.00 |
| Jun 30, 2024 | 378,000.00 |
| Mar 31, 2024 | 786,000.00 |
| Dec 31, 2023 | 585,000.00 |
| Sep 30, 2023 | 77,000.00 |
| Jun 30, 2023 | 107,000.00 |
| Dec 31, 2022 | 34,000.00 |